3,4-dihydroxyphenylacetic acid has been researched along with cysteine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Beal, MF; Matson, WR; Miller, JM; Uemura, Y | 1 |
| Craig, R; Terry, LC | 1 |
| Hastings, TG; Zigmond, MJ | 1 |
| Correa, JG; Stoppani, AO | 1 |
| Hastings, TG; Lewis, DA; Zigmond, MJ | 1 |
| Ebinger, G; Michotte, Y; Pravda, M; Sarre, S; Thorré, K | 1 |
| Daniel, SE; Halliwell, B; Jenner, P; Lees, AJ; Marsden, DC; Spencer, JP | 1 |
| Hastings, TG; Lewis, DA; Rabinovic, AD | 1 |
| Halliwell, B; Jenner, P; Spencer, JP; Whiteman, M | 1 |
| Anderson, EJ; Builta, ZJ; Doorn, JA; Monroe, TB; Nelson, MM | 1 |
| Anderson, EJ; Crawford, RA; Doorn, JA; Gilardoni, E; Monroe, TB; Regazzoni, L | 1 |
11 other study(ies) available for 3,4-dihydroxyphenylacetic acid and cysteine
| Article | Year |
|---|---|
Neurochemical analysis of focal ischemia in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cysteine; Free Radicals; Glutathione; Guanosine; Hydroxyindoleacetic Acid; Ischemic Attack, Transient; Rats; Rats, Inbred Strains; Serotonin; Tryptophan; Uric Acid; Xanthine Oxidase | 1991 |
Cysteamine effects on monoamines, dopamine-beta-hydroxylase and the hypothalamic-pituitary axis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Arcuate Nucleus of Hypothalamus; Catecholamines; Corticosterone; Cysteamine; Cysteine; Dopamine beta-Hydroxylase; Growth Hormone; Hypothalamo-Hypophyseal System; Hypothalamus; Male; Prolactin; Rats; Rats, Inbred Strains; Thyrotropin; Ventromedial Hypothalamic Nucleus | 1985 |
Identification of catechol-protein conjugates in neostriatal slices incubated with [3H]dopamine: impact of ascorbic acid and glutathione.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Catechols; Chromatography, High Pressure Liquid; Cysteine; Dopamine; Glutathione; Male; Neostriatum; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Tritium | 1994 |
Catecholamines enhance dihydrolipoamide dehydrogenase inactivation by the copper Fenton system. Enzyme protection by copper chelators.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding Sites; Captopril; Catecholamines; Catechols; Cattle; Chelating Agents; Copper; Cysteine; Dihydrolipoamide Dehydrogenase; Dopamine; Epinephrine; Hydrogen Peroxide; Hydroxyl Radical; Iron; Kinetics; Mammals; Norepinephrine; Oxidation-Reduction; Oxidopamine; Penicillamine | 1996 |
Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catechols; Cysteine; Dopamine; Free Radicals; Histocytochemistry; Male; Nervous System Diseases; Oxidation-Reduction; Parkinson Disease; Protein Binding; Quinones; Rats; Rats, Sprague-Dawley | 1996 |
New antioxidant mixture for long term stability of serotonin, dopamine and their metabolites in automated microbore liquid chromatography with dual electrochemical detection.
Topics: 3,4-Dihydroxyphenylacetic Acid; Antioxidants; Ascorbic Acid; Chromatography, Liquid; Cysteine; Dopamine; Drug Stability; Edetic Acid; Electrochemistry; Homovanillic Acid; Hydrogen-Ion Concentration; Hydroxyindoleacetic Acid; Microdialysis; Oxidation-Reduction; Reproducibility of Results; Sensitivity and Specificity; Serotonin | 1997 |
Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.
Topics: 3,4-Dihydroxyphenylacetic Acid; 8,11,14-Eicosatrienoic Acid; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Copper; Cysteine; Dihydroxyphenylalanine; Dopamine; Glutathione; Humans; Hypoxanthine; Iron; Parkinson Disease; Reactive Oxygen Species; Reference Values; Superoxides; Xanthine | 1998 |
Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cysteine; Dopamine; Down-Regulation; Extracellular Space; Glutathione; Male; Neostriatum; Nerve Degeneration; Oxidative Stress; Parkinson Disease; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tyrosine 3-Monooxygenase | 2000 |
5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caspase 3; Caspases; Catecholamines; Cell Survival; Cells, Cultured; Cysteine; Cysteinyldopa; DNA; Dopamine; Dose-Response Relationship, Drug; Enzyme Activation; Intracellular Fluid; Levodopa; Methamphetamine; Neurons; Purines; Pyrimidines; Rats; Reactive Oxygen Species | 2002 |
Biochemical characterization of the catecholaldehyde reactivity of L-carnosine and its therapeutic potential in human myocardium.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aldehydes; Carnosine; Catechols; Cysteine; Glutathione; Humans; Middle Aged; Mitochondria; Myocardium; Oxidation-Reduction | 2019 |
Characterization of Catecholaldehyde Adducts with Carnosine and l-Cysteine Reveals Their Potential as Biomarkers of Catecholaminergic Stress.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Carnosine; Catechols; Cell Line, Tumor; Cysteine; Humans; Mice; Mice, Inbred C57BL; Molecular Structure; Monoamine Oxidase | 2021 |